| Product Code: ETC7658768 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Peripheral Vasodilator Drugs Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Peripheral Vasodilator Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Peripheral Vasodilator Drugs Market - Industry Life Cycle |
3.4 Israel Peripheral Vasodilator Drugs Market - Porter's Five Forces |
3.5 Israel Peripheral Vasodilator Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Israel Peripheral Vasodilator Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Peripheral Vasodilator Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of peripheral artery disease in Israel |
4.2.2 Growing geriatric population requiring peripheral vasodilator drugs |
4.2.3 Technological advancements in drug delivery systems for peripheral vasodilators |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Israel |
4.3.2 High cost associated with peripheral vasodilator drugs |
4.3.3 Limited awareness and diagnosis of peripheral artery disease in Israel |
5 Israel Peripheral Vasodilator Drugs Market Trends |
6 Israel Peripheral Vasodilator Drugs Market, By Types |
6.1 Israel Peripheral Vasodilator Drugs Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Peripheral Vasodilator Drugs Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 Israel Peripheral Vasodilator Drugs Market Revenues & Volume, By Calcium Channel Blockers, 2021- 2031F |
6.1.4 Israel Peripheral Vasodilator Drugs Market Revenues & Volume, By Direct-acting Vasodilators, 2021- 2031F |
6.1.5 Israel Peripheral Vasodilator Drugs Market Revenues & Volume, By Alpha-adrenergic Blockers, 2021- 2031F |
6.1.6 Israel Peripheral Vasodilator Drugs Market Revenues & Volume, By Potassium Channel Activators, 2021- 2031F |
6.1.7 Israel Peripheral Vasodilator Drugs Market Revenues & Volume, By Nitrates, 2021- 2031F |
6.1.8 Israel Peripheral Vasodilator Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Peripheral Vasodilator Drugs Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Israel Peripheral Vasodilator Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.2.3 Israel Peripheral Vasodilator Drugs Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.2.4 Israel Peripheral Vasodilator Drugs Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Israel Peripheral Vasodilator Drugs Market Import-Export Trade Statistics |
7.1 Israel Peripheral Vasodilator Drugs Market Export to Major Countries |
7.2 Israel Peripheral Vasodilator Drugs Market Imports from Major Countries |
8 Israel Peripheral Vasodilator Drugs Market Key Performance Indicators |
8.1 Number of new drug approvals for peripheral vasodilator drugs in Israel |
8.2 Percentage increase in the use of minimally invasive procedures for peripheral artery disease treatment |
8.3 Adoption rate of advanced drug delivery systems for peripheral vasodilator drugs in Israel |
9 Israel Peripheral Vasodilator Drugs Market - Opportunity Assessment |
9.1 Israel Peripheral Vasodilator Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Israel Peripheral Vasodilator Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Peripheral Vasodilator Drugs Market - Competitive Landscape |
10.1 Israel Peripheral Vasodilator Drugs Market Revenue Share, By Companies, 2024 |
10.2 Israel Peripheral Vasodilator Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here